Recorded device evidence

Sentinella 102, Sentinella 102 Horus (K162052): indications, design and recorded evidence

The acquired K162052 file contains product-specific indications and users, design and operating principle, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Source limits that change the comparison

Qualified interpretation and the intraoperative sheath matter

The recorded gamma-camera indication requires images to be interpreted by qualified personnel and permits intraoperative use if a protective sheath is used. It also names bedside, emergency-room and intensive-care settings. These are dated source limits, not permission for an unsupported new use. [2]

Prepare or ask: Compare user qualification, clinical setting and the protective-sheath configuration against the proposed label and workflow; identify the evidence for any change.

Dated manufacturer-submitted summary; current buyer applicability remains unresolved. PDF page 5 ↗

Optical registration does not replace the gamma image

The Horus description adds an optical camera and co-registers its image with the gamma image in real time. It expressly says the gamma image is not reprocessed or modified during that process. That distinction belongs in the configuration and software comparison. [3]

Prepare or ask: Compare optical/gamma registration, alignment, image-processing boundaries and software behavior with the proposed system; identify changes and their evidence.

Dated manufacturer-submitted summary; current buyer applicability remains unresolved. PDF page 4 ↗

Manufacturer certification wording is not FDA endorsement

The performance passage uses the manufacturer’s wording that previous models were already certificated by FDA and relies on previous NEMA NU-1:2007 testing. Preserve that dated account; it does not establish a current FDA certification, endorsement or universal permission to reuse a test report. [4]

Prepare or ask: Obtain the actual historical decision and NEMA reports, tested collimator/configuration and rationale for reusing evidence. Review present scope separately; do not turn manufacturer wording into a certification badge.

Dated manufacturer-submitted summary; current buyer applicability remains unresolved. PDF page 6 ↗

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 2 selected decisions under primary code IYX. 2 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K162052 ↗ · this pageSentinella 102, Sentinella 102 Horus2016-07-25 → 2016-08-1824Special
K230221 ↗QDOSE® Multi-purpose Voxel Dosimetry (Personalized Dosimetry in Molecular Radiotherapy)2023-01-26 → 2023-08-28214Traditional
K212587 ↗3D-RD-S2021-08-16 → 2023-02-22555Traditional
K163687 ↗OLINDA EXM2016-12-28 → 2017-07-19203Traditional
K160933 ↗Discovery NM 750b Bopsy2016-04-04 → 2016-11-18228Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K162052 · PDF page 5 ↗ Source 2

Sentinella  102     (models  Sentinella  102  and  Sentinella  102  Horus)              is  a  mobile
                      gamma   camera   system   which   is   intended              for   imaging   the   distribution   of
                      radionuclides in the human body by means of photon detection.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K162052 · PDF page 4 ↗ Source 3

Sentinella  102  is  a  currently  marketed  portable  gamma  camera  system  which
                      includes  a  small  gamma  camera  designed  to  obtain  images  from  small  organs
                      and structures labeled using radionuclides emitting gamma                 -rays.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Performance evidence actually described

K162052 · PDF page 6 ↗ Source 4

Sentinella 102 (models Sentinella 102 and Sentinella 102 Horus) has the same
                      performance  specifications  than  the  previous  models             already  certificated  by  the
                      FDA  (predicates).       Because  of  this,  no  new  NEMA  performance  tests                 were
                      necessary for the present submission.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK162052 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categorySentinella 102, Sentinella 102 Horus [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantGeneral Equipment For Medical Imaging (Oncovision- [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeIYX [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2016-08-18 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeSpecial [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2016-07-25 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[23707] · record 8579bba4fca27e989561ba5b5ab22cc1e108f9c97613de269fb66a46f8d94ded
  • [5] Complete results array / fda-decision-context:K162052 · record whole dataset partition

FDA 510(k) summary — K162052 ↗

Mon, 05 Sep 2016 14:17:22 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot b3d11902c7d537c82112dc4bf41e4f6de59282fce0727cb7e3bb40d0dd798f0f

  • [2] PDF page 5 · record 8fee6241b6b69078258f85c2c51a206aab19b7f0bbd42bb2d0045ef59c69fbf9
  • [3] PDF page 4 · record 1c30051253225f4de7ed5c00d194a119b962c0a1c8be854b9c736623a583f224
  • [4] PDF page 6 · record 32903148dac511bf30ccc29f72d8354e7d5d49c28897f7e2e9da711495d1a4f8

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services